Target intelligence / Profile preview

Systemic paracrine milieu

Molecular classification
Other
01

Overview

The systemic paracrine milieu refers to the collective environment of circulating and locally acting signaling factors, including cytokines, chemokines, growth factors, and extracellular vesicles, that regulate cellular function and tissue homeostasis (Conboy et al., 2005, Nature). It is not a single molecular target but a physiological state representing the sum of intercellular communication signals throughout the body (Villeda et al., 2014, Nature Medicine). In aging and chronic disease, this milieu undergoes significant shifts, such as the accumulation of pro-inflammatory factors known as the Senescence-Associated Secretory Phenotype (SASP), which can impair stem cell function and promote tissue degeneration (Acosta et al., 2013, Nature Cell Biology). Therapeutic interventions like heterochronic parabiosis, therapeutic plasma exchange, or senolytic drugs aim to 'rejuvenate' or 'normalize' this milieu to restore regenerative capacity and improve healthspan (Lehallier et al., 2019, Nature Medicine). Because it involves a vast array of heterogeneous components rather than a discrete receptor or enzyme, it is categorized as a systemic physiological environment rather than a traditional drug target (Katsimpardi et al., 2014, Science).

Other names
Systemic environmentCirculating milieuHumoral environmentParacrine signaling environmentSystemic signaling milieu
02

Mechanism of action

Modulation of the collective signaling environment by removing deleterious pro-inflammatory or pro-senescent factors (e.g., via senolytics or plasma exchange) or by replenishing beneficial regenerative factors to restore youthful tissue function.

03

Biological functions

Signal transductionCell-to-cell communicationHomeostasisTissue repairImmune modulationStem cell niche regulation
04

Disease associations

AgingCancerInflammationNeurodegenerative diseaseCardiovascular disease
05

Safety considerations

Systemic off-target effects due to the complexity of the signaling networkDisruption of essential homeostatic signaling pathwaysPotential for unintended immune suppression or activationDifficulty in achieving precise control over multi-factor interactions
06

Interacting drugs

Dasatinib

5 more in the full profile.

07

Biomarkers

Growth differentiation factor 11 (GDF11)Interleukin-6 (IL-6)Tumor necrosis factor alpha (TNF-alpha)Senescence-associated secretory phenotype (SASP) factorsC-reactive protein (CRP)

Beyond the preview

Go deeper on Systemic paracrine milieu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systemic paracrine milieu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call